Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Kineta, Inc./de (KANT) since 2016 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Kineta, Inc./de. Table 2 shows the detailed insider transactions. This company's CIK number is 1445283.
Total stock buying since 2016: $56,510,640.
Total stock sales since 2016: $9,378,943.
Total stock option exercises since 2016: $432,375.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 0 | $0 | 995,658 | $405,389 |
| 2023 | 60,250 | $160,074 | 6,113 | $26,583 | 192,789 | $26,986 |
| 2022 | 0 | $0 | 35,079 | $53,132 | 0 | $0 |
| 2019 | 0 | $0 | 1,331,343 | $3,370,438 | 144,287 | $0 |
| 2018 | 40,000 | $270,000 | 0 | $0 | 0 | $0 |
| 2017 | 4,104,000 | $20,520,000 | 761,327 | $5,928,790 | 0 | $0 |
| 2016 | 3,398,120 | $35,560,566 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-06 | 0 | $0 | 0 | $0 | 995,658 | $405,389 |
| 2023-12 | 2,250 | $9,950 | 0 | $0 | 0 | $0 |
| 2023-11 | 8,000 | $27,211 | 0 | $0 | 0 | $0 |
| 2023-10 | 0 | $0 | 0 | $0 | 4,443 | $622 |
| 2023-09 | 35,000 | $79,113 | 0 | $0 | 0 | $0 |
| 2023-06 | 15,000 | $43,800 | 0 | $0 | 188,346 | $26,364 |
| 2023-03 | 0 | $0 | 6,113 | $26,583 | 0 | $0 |
| 2022-07 | 0 | $0 | 4,584 | $8,475 | 0 | $0 |
| 2022-06 | 0 | $0 | 17,822 | $21,295 | 0 | $0 |
| 2022-03 | 0 | $0 | 10,715 | $19,779 | 0 | $0 |
| 2022-02 | 0 | $0 | 1,958 | $3,583 | 0 | $0 |
| 2019-11 | 0 | $0 | 1,283,919 | $3,228,557 | 0 | $0 |
| 2019-02 | 0 | $0 | 45,112 | $134,945 | 144,287 | $0 |
| 2019-01 | 0 | $0 | 2,312 | $6,936 | 0 | $0 |
| 2018-10 | 40,000 | $270,000 | 0 | $0 | 0 | $0 |
| 2017-12 | 4,104,000 | $20,520,000 | 504,027 | $2,461,163 | 0 | $0 |
| 2017-03 | 0 | $0 | 214,300 | $2,841,677 | 0 | $0 |
| 2017-02 | 0 | $0 | 43,000 | $625,950 | 0 | $0 |
| 2016-12 | 687,567 | $7,336,227 | 0 | $0 | 0 | $0 |
| 2016-11 | 818,247 | $8,124,361 | 0 | $0 | 0 | $0 |
| 2016-09 | 992,306 | $12,899,978 | 0 | $0 | 0 | $0 |
| 2016-02 | 900,000 | $7,200,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-23 | Dylla Scott J. | Option Ex | 12,500 | .61 | 7,637 |
| 2025-06-23 | Iadonato Shawn | Option Ex | 237,500 | .49 | 115,425 |
| 2025-06-23 | Guillaudeux Thierry (Chief Scientific Officer) | Option Ex | 225,000 | .36 | 81,000 |
| 2025-06-23 | Baker Keith (Chief Financial Officer) | Option Ex | 225,000 | .36 | 81,000 |
| 2025-06-23 | Bartoszek Raymond J. | Option Ex | 12,500 | .61 | 7,637 |
| 2025-06-23 | Peters Richard | Option Ex | 12,500 | .61 | 7,637 |
| 2025-06-23 | Foote Marion R | Option Ex | 12,500 | .61 | 7,637 |
| 2025-06-23 | Philips Craig W. (President and Secretary) | Option Ex | 225,000 | .36 | 81,000 |
| 2025-06-23 | Drapkin Kimberlee C | Option Ex | 12,500 | .61 | 7,637 |
| 2025-06-23 | Arkowitz David | Option Ex | 12,500 | .61 | 7,637 |
| 2025-06-17 | Foote Marion R | Option Ex | 8,158 | .14 | 1,142 |
| 2023-12-06 | Bartoszek Raymond J. (Director) | Buy | 250 | 4.50 | 1,125 |
| 2023-12-05 | Bartoszek Raymond J. (Director) | Buy | 1,000 | 4.50 | 4,500 |
| 2023-12-04 | Bartoszek Raymond J. (Director) | Buy | 1,000 | 4.33 | 4,325 |
| 2023-11-29 | Iadonato Shawn (Chief Executive Officer) | Buy | 4,100 | 3.51 | 14,403 |
| 2023-11-28 | Iadonato Shawn (Chief Executive Officer) | Buy | 900 | 3.33 | 2,995 |
| 2023-11-28 | Philips Craig W. (President) | Buy | 3,000 | 3.27 | 9,813 |
| 2023-10-11 | Foote Marion R (Director) | Option Ex | 4,443 | .14 | 622 |
| 2023-09-21 | Philips Craig W. (President) | Buy | 2,900 | 2.40 | 6,968 |
| 2023-09-20 | Iadonato Shawn (Chief Executive Officer) | Buy | 10,000 | 2.50 | 25,040 |
| 2023-09-20 | Kenny Pauline (General Counsel & Secretary) | Buy | 1,500 | 2.58 | 3,870 |
| 2023-09-20 | Philips Craig W. (President) | Buy | 600 | 2.54 | 1,525 |
| 2023-09-19 | Bartoszek Raymond J. (Director) | Buy | 2,000 | 2.37 | 4,746 |
| 2023-09-18 | Baker Keith (Chief Financial Officer) | Buy | 5,000 | 2.13 | 10,674 |
| 2023-09-18 | Bartoszek Raymond J. (Director) | Buy | 2,500 | 2.08 | 5,200 |
| 2023-09-15 | Bartoszek Raymond J. (Director) | Buy | 500 | 2.18 | 1,090 |
| 2023-09-14 | Guillaudeux Thierry (Chief Scientific Officer) | Buy | 10,000 | 2.00 | 20,000 |
| 2023-06-16 | Baker Keith (Chief Financial Officer) | Buy | 10,000 | 2.92 | 29,200 |
| 2023-06-14 | Iadonato Shawn (Chief Executive Officer) | Option Ex | 2,764 | .14 | 386 |
| 2023-06-14 | Bartoszek Raymond J. (Director) | Option Ex | 120,036 | .14 | 16,804 |
| 2023-06-14 | Philips Craig W. (President) | Option Ex | 2,764 | .14 | 386 |
| 2023-03-20 | Iadonato Shawn (Chief Executive Officer) | Sale | 1,119 | 3.29 | 3,678 |
| 2023-03-20 | Kenny Pauline (General Counsel & Secretary) | Sale | 544 | 3.29 | 1,788 |
| 2023-03-20 | Philips Craig W. (President) | Sale | 872 | 3.29 | 2,866 |
| 2023-03-17 | Iadonato Shawn (Chief Executive Officer) | Sale | 1,580 | 5.08 | 8,029 |
| 2023-03-17 | Kenny Pauline (General Counsel & Secretary) | Sale | 767 | 5.08 | 3,898 |
| 2023-03-17 | Philips Craig W. (President) | Sale | 1,231 | 5.14 | 6,324 |
| 2022-07-05 | Peters Richard (President and CEO) | Sale | 4,584 | 1.85 | 8,475 |
| 2022-06-03 | Wyzga Michael D (See Remarks) | Sale | 2,887 | 1.20 | 3,449 |
| 2022-06-03 | Epstein Marie (Principal Accounting Officer) | Sale | 1,806 | 1.20 | 2,158 |
| 2022-06-03 | Smith Devin Whittemore (SVP and General Counsel) | Sale | 2,923 | 1.20 | 3,492 |
| 2022-06-03 | Peters Richard (President and CEO) | Sale | 10,206 | 1.20 | 12,196 |
| 2022-03-28 | Peters Richard (President and CEO) | Sale | 10,715 | 1.85 | 19,779 |
| 2022-02-03 | Mohsen Paulash (Chief Business Officer) | Sale | 1,958 | 1.83 | 3,583 |
| 2019-11-27 | Sandell Scott D (10% Owner) | Sale | 1,166,755 | 2.52 | 2,941,389 |
| 2019-11-26 | Sandell Scott D (10% Owner) | Sale | 117,164 | 2.45 | 287,168 |
| 2019-02-04 | Gilmartin Geoffrey S. (Chief Development Officer) | Sale | 9,189 | 2.99 | 27,484 |
| 2019-02-04 | Munoz Benito (Chief Scientific Officer) | Sale | 9,514 | 2.99 | 28,456 |
| 2019-02-04 | Lee Po Shun (See Remarks) | Sale | 9,931 | 2.99 | 29,703 |
| 2019-02-04 | Chhabra Meenu (President and CEO) | Sale | 16,478 | 2.99 | 49,302 |
| 2019-02-01 | Zecevic Marija (Chief Operating Officer) | Option Ex | 22,313 | .00 | 0 |
| 2019-02-01 | Gilmartin Geoffrey S. (Chief Development Officer) | Option Ex | 24,100 | .00 | 0 |
| 2019-02-01 | Munoz Benito (Chief Scientific Officer) | Option Ex | 24,953 | .00 | 0 |
| 2019-02-01 | Lee Po Shun (See Remarks) | Option Ex | 26,046 | .00 | 0 |
| 2019-02-01 | Chhabra Meenu (President and CEO) | Option Ex | 46,875 | .00 | 0 |
| 2019-01-29 | Lee Po Shun (See Remarks) | Sale | 712 | 3.00 | 2,136 |
| 2019-01-28 | Lee Po Shun (See Remarks) | Sale | 1,600 | 3.00 | 4,800 |
| 2018-10-26 | Berger Franklin M (Director) | Buy | 40,000 | 6.75 | 270,000 |
| 2017-12-18 | Kelly Jeffery W. (Director) | Buy | 4,000 | 5.00 | 20,000 |
| 2017-12-18 | Chhabra Meenu (President and CEO) | Buy | 40,000 | 5.00 | 200,000 |
| 2017-12-18 | Berger Franklin M (Director) | Buy | 60,000 | 5.00 | 300,000 |
| 2017-12-18 | Sandell Scott D (10% Owner) | Buy | 2,000,000 | 5.00 | 10,000,000 |
| 2017-12-18 | Barrett M James (Director) | Buy | 2,000,000 | 5.00 | 10,000,000 |
| 2017-12-14 | Cormorant Global Healthcare Master Fund, Lp | Sale | 504,027 | 4.88 | 2,461,163 |
| 2017-03-13 | Fmr Llc (Other) | Sale | 25,000 | 12.94 | 323,500 |
| 2017-03-10 | Fmr Llc (Other) | Sale | 25,000 | 12.04 | 301,000 |
| 2017-03-09 | Fmr Llc (Other) | Sale | 4,300 | 11.90 | 51,152 |
| 2017-03-08 | Fmr Llc (Other) | Sale | 25,000 | 12.10 | 302,500 |
| 2017-03-07 | Fmr Llc (Other) | Sale | 35,000 | 13.13 | 459,550 |
| 2017-03-06 | Fmr Llc (Other) | Sale | 25,000 | 13.31 | 332,750 |
| 2017-03-03 | Fmr Llc (Other) | Sale | 20,000 | 13.63 | 272,600 |
| 2017-03-02 | Fmr Llc (Other) | Sale | 25,000 | 14.30 | 357,625 |
| 2017-03-01 | Fmr Llc (Other) | Sale | 30,000 | 14.70 | 441,000 |
| 2017-02-28 | Fmr Llc (Other) | Sale | 15,000 | 14.47 | 217,050 |
| 2017-02-27 | Fmr Llc (Other) | Sale | 15,000 | 14.65 | 219,750 |
| 2017-02-24 | Fmr Llc (Other) | Sale | 13,000 | 14.55 | 189,150 |
| 2016-12-16 | Berger Franklin M (Director) | Buy | 14,000 | 11.52 | 161,336 |
| 2016-12-15 | Berger Franklin M (Director) | Buy | 26,000 | 10.99 | 285,636 |
| 2016-12-13 | Cormorant Global Healthcare Master Fund, Lp | Buy | 21,301 | 10.98 | 233,948 |
| 2016-12-12 | Cormorant Global Healthcare Master Fund, Lp | Buy | 100,000 | 10.79 | 1,079,000 |
| 2016-12-08 | Cormorant Global Healthcare Master Fund, Lp | Buy | 21,819 | 10.93 | 238,481 |
| 2016-12-07 | Cormorant Global Healthcare Master Fund, Lp | Buy | 22,598 | 10.74 | 242,702 |
| 2016-12-06 | Cormorant Global Healthcare Master Fund, Lp | Buy | 24,648 | 10.89 | 268,317 |
| 2016-12-05 | Cormorant Global Healthcare Master Fund, Lp | Buy | 89,271 | 10.78 | 962,607 |
| 2016-12-02 | Cormorant Global Healthcare Master Fund, Lp | Buy | 150,000 | 10.48 | 1,571,400 |
| 2016-12-01 | Cormorant Global Healthcare Master Fund, Lp | Buy | 41,984 | 10.11 | 424,584 |
| 2016-11-29 | Cormorant Global Healthcare Master Fund, Lp | Buy | 128,407 | 10.28 | 1,319,510 |
| 2016-11-23 | Cormorant Global Healthcare Master Fund, Lp | Buy | 180,500 | 11.02 | 1,989,290 |
| 2016-11-22 | Cormorant Global Healthcare Master Fund, Lp | Buy | 69,500 | 11.08 | 769,851 |
| 2016-11-21 | Cormorant Global Healthcare Master Fund, Lp | Buy | 111,863 | 11.64 | 1,302,644 |
| 2016-11-07 | Cormorant Global Healthcare Master Fund, Lp | Buy | 231,700 | 8.69 | 2,012,546 |
| 2016-11-04 | Cormorant Global Healthcare Master Fund, Lp | Buy | 76,000 | 7.68 | 583,756 |
| 2016-11-03 | Cormorant Global Healthcare Master Fund, Lp | Buy | 20,277 | 7.24 | 146,764 |
| 2016-09-14 | Berger Franklin M (Director) | Buy | 69,230 | 13.00 | 899,990 |
| 2016-09-14 | Sandell Scott D (10% Owner) | Buy | 461,538 | 13.00 | 5,999,994 |
| 2016-09-14 | Barrett M James (Director) | Buy | 461,538 | 13.00 | 5,999,994 |
| 2016-02-17 | Perrigo Science One Ltd. | Buy | 125,000 | 8.00 | 1,000,000 |
| 2016-02-17 | Berger Franklin M (Director) | Buy | 25,000 | 8.00 | 200,000 |
| 2016-02-17 | Novartis Ag (10% Owner) | Buy | 375,000 | 8.00 | 3,000,000 |
| 2016-02-17 | Fmr Llc (Other) | Buy | 375,000 | 8.00 | 3,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of KANT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Kineta, Inc./de (symbol KANT, CIK number 1445283) see the Securities and Exchange Commission (SEC) website.